Literature DB >> 33479403

Role of osteogenic Dickkopf-1 in bone remodeling and bone healing in mice with type I diabetes mellitus.

Nick Hildebrandt1, Juliane Colditz1,2, Lorenz C Hofbauer1, Martina Rauner3, Caio Dutra1,4, Paula Goes1,5, Juliane Salbach-Hirsch1, Sylvia Thiele1.   

Abstract

Type 1 diabetes mellitus (T1DM) is associated with low bone mass and a higher risk for fractures. Dickkopf-1 (Dkk1), which inhibits Wnt signaling, osteoblast function, and bone formation, has been found to be increased in the serum of patients with T1DM. Here, we investigated the functional role of Dkk1 in T1DM-induced bone loss in mice. T1DM was induced in 10-week-old male mice with Dkk1-deficiency in late osteoblasts/osteocytes (Dkk1f/f;Dmp1-Cre, cKO) and littermate control mice by 5 subsequent injections of streptozotocin (40 mg/kg). Age-matched, non-diabetic control groups received citrate buffer instead. At week 12, calvarial defects were created in subgroups of each cohort. After a total of 16 weeks, weight, fat, the femoral bone phenotype and the area of the bone defect were analyzed using µCT and dynamic histomorphometry. During the experiment, diabetic WT and cKO mice did not gain body weight compared to control mice. Further they lost their perigonadal and subcutaneous fat pads. Diabetic mice had highly elevated serum glucose levels and impaired glucose tolerance, regardless of their Dkk1 levels. T1DM led to a 36% decrease in trabecular bone volume in Cre- negative control animals, whereas Dkk1 cKO mice only lost 16%. Of note, Dkk1 cKO mice were completely protected from T1DM-induced cortical bone loss. T1DM suppressed the bone formation rate, the number of osteoblasts at trabecular bone, serum levels of P1NP and bone defect healing in both, Dkk1-deficient and sufficient, mice. This may be explained by increased serum sclerostin levels in both genotypes and the strict dependence on bone formation for bone defect healing. In contrast, the number of osteoclasts and TRACP 5b serum levels only increased in diabetic control mice, but not in Dkk1 cKO mice. In summary, Dkk1 derived from osteogenic cells does not influence the development of T1DM but plays a crucial role in T1DM-induced bone loss in male mice by regulating osteoclast numbers.

Entities:  

Year:  2021        PMID: 33479403     DOI: 10.1038/s41598-021-81543-7

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  54 in total

1.  Influence of nonenzymatic glycation on biomechanical properties of cortical bone.

Authors:  D Vashishth; G J Gibson; J I Khoury; M B Schaffler; J Kimura; D P Fyhrie
Journal:  Bone       Date:  2001-02       Impact factor: 4.398

2.  Advanced glycation endproducts interefere with integrin-mediated osteoblastic attachment to a type-I collagen matrix.

Authors:  Antonio Desmond McCarthy; Toshimasa Uemura; Susana Beatriz Etcheverry; Ana María Cortizo
Journal:  Int J Biochem Cell Biol       Date:  2004-05       Impact factor: 5.085

3.  Deficits in Trabecular Bone Microarchitecture in Young Women With Type 1 Diabetes Mellitus.

Authors:  Naiemh Abdalrahaman; Christie McComb; John E Foster; John McLean; Robert S Lindsay; John McClure; Martin McMillan; Russell Drummond; Derek Gordon; Gerard A McKay; M Guftar Shaikh; Colin G Perry; S Faisal Ahmed
Journal:  J Bone Miner Res       Date:  2015-08       Impact factor: 6.741

4.  Advanced glycation end-products attenuate human mesenchymal stem cells and prevent cognate differentiation into adipose tissue, cartilage, and bone.

Authors:  Shinichiro Kume; Seiya Kato; Sho-ichi Yamagishi; Yosuke Inagaki; Seiji Ueda; Nobuyuki Arima; Takahiro Okawa; Masamichi Kojiro; Kensei Nagata
Journal:  J Bone Miner Res       Date:  2005-05-23       Impact factor: 6.741

Review 5.  Systematic review of type 1 and type 2 diabetes mellitus and risk of fracture.

Authors:  Mohsen Janghorbani; Rob M Van Dam; Walter C Willett; Frank B Hu
Journal:  Am J Epidemiol       Date:  2007-06-16       Impact factor: 4.897

6.  Influence of age, sex, and insulin on osteoblast function: osteoblast dysfunction in diabetes mellitus.

Authors:  R Bouillon; M Bex; E Van Herck; J Laureys; L Dooms; E Lesaffre; E Ravussin
Journal:  J Clin Endocrinol Metab       Date:  1995-04       Impact factor: 5.958

7.  Incidence of diabetes in youth in the United States.

Authors:  Dana Dabelea; Ronny A Bell; Ralph B D'Agostino; Giuseppina Imperatore; Judith M Johansen; Barbara Linder; Lenna L Liu; Beth Loots; Santica Marcovina; Elizabeth J Mayer-Davis; David J Pettitt; Beth Waitzfelder
Journal:  JAMA       Date:  2007-06-27       Impact factor: 56.272

Review 8.  Type 1 diabetes.

Authors:  Mark A Atkinson; George S Eisenbarth; Aaron W Michels
Journal:  Lancet       Date:  2013-07-26       Impact factor: 79.321

Review 9.  Osteoporosis in patients with diabetes mellitus.

Authors:  Lorenz C Hofbauer; Carolin C Brueck; Shiv K Singh; Harald Dobnig
Journal:  J Bone Miner Res       Date:  2007-09       Impact factor: 6.741

10.  Complications after hip fracture surgery: are they preventable?

Authors:  E R Flikweert; K W Wendt; R L Diercks; G J Izaks; D Landsheer; M Stevens; I H F Reininga
Journal:  Eur J Trauma Emerg Surg       Date:  2017-08-09       Impact factor: 3.693

View more
  1 in total

Review 1.  Mouse models of type 1 diabetes and their use in skeletal research.

Authors:  Evangelia Kalaitzoglou; John L Fowlkes; Kathryn M Thrailkill
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2022-06-24       Impact factor: 3.626

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.